Development and evaluation of novel InhA inhibitors inspired by thiadiazole and tetrahydropyran series of inhibitors
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a leading global health challenge, exacerbated by the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. One promising therapeutic target is the enzyme enoyl-acyl carrier protein reductase (InhA), whic...
Saved in:
| Main Authors: | Rambaher Martina Hrast, Gradišek Nina, Frlan Rok, Sosič Izidor, Bolje Aljoša, Kljun Jakob, Juhás Martin, Gobec Stanislav, Pajk Stane |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2025-06-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2025-0016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Designing Novel InhA Inhibitors for Antituberculosis Agents Using ab Initio Fragment Molecular Orbital Calculations
by: Thimpika Pornprom, et al.
Published: (2025-07-01) -
Biochemical characteristics of the 6-nitro regioisomer of nitroxoline and its 1,2,3,4-tetrahydroquinoline analogues
by: Mitrović Ana, et al.
Published: (2025-06-01) -
Bioconversion of Alpha-Cembratriene-4,6-diol into High-Value Compound Farnesal Through Employment of a Novel <i>Stenotrophomonas maltophilia</i> H3-1 Strain
by: Shen Huang, et al.
Published: (2025-02-01) -
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
by: Valentina Gerussi, et al.
Published: (2025-03-01) -
Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s)
by: Grabrijan Katarina, et al.
Published: (2024-09-01)